Evidence map›Paper›PMID 29692694›Full record

ArticleCurrent urology2018

Anti-Cancer Effects of

Denglu Zhang, Kailin Li, Chao Sun, Guangshang Cao, Yuanfu Qi, Zhaomin Lin, Yanxia Guo, Zhiyong Liu, Yuan Chen, Jiaxin Liu and 8 more

Open access · diamondAbstract read
In one paragraph

Article in Current urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Polyphyllin I InhibitsEvidence-based complementary and alternative medicine : eCAM · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Denglu ZhangThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The Second Hospital of Shandong University, Jinan, China.
Kailin LiDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Chao SunDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Guangshang CaoThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The Second Hospital of Shandong University, Jinan, China.
Yuanfu QiThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The Second Hospital of Shandong University, Jinan, China.
Zhaomin LinDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Yanxia GuoDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Zhiyong LiuThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The Second Hospital of Shandong University, Jinan, China.
Yuan ChenDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Jiaxin LiuThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The Second Hospital of Shandong University, Jinan, China.
Guanghui ChengDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Peng WangDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Lu ZhangDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Jianye ZhangDepartment of Urology, The Second Hospital of Shandong University, Jinan, China.
Jiliang WenDepartment of Urology, The Second Hospital of Shandong University, Jinan, China.
Dawei XuDepartment of Medicine, Division of Hematology and Centre for Molecular Medicine, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden.
Feng KongDepartment of Central Research Laboratory, The Second Hospital of Shandong University, Jinan, China.
Shengtian ZhaoThe Affiliated Hospital of Shandong University of Traditional Chinese Medicine, The Second Hospital of Shandong University, Jinan, China.
Second Hospital of Shandong University · CNKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the potential anti-prostate cancer effects of MATERIALS AND

methodsThe anti-proliferation activity of PPEE was tested on PC3 and DU145 cells using Cell Counting Kit-8 assay. The pro-apoptotic and cell cycle arrest effects of PPEE were confirmed by flow cytometry. Apoptosis of prostate cancer cells was induced by PPEE through endogenous and exogenous pathways. A mouse xenograft model was used to examine its anti-prostate cancer effects

resultsWe found that the IC50 of PPEE on PC3 cells was 3.98 µg/ml and the IC50 of PPEE on DU145 cells was 8 µg/ml. PPEE induced prostate cancer cell apoptosis in a concentration dependent manner, through endogenous and exogenous pathways. PPEE induced PC3 cell cycle arrest in G0/G1 and G2/M phases, while in DU145cell it induced cell arrest in the G0/G1 phase. PPEE inhibited the growth of prostate cancer cells

conclusionPPEE could inhibit prostate cancer growth

Indexed as

Cell appotosisCycle arrestParis polyphyllaProstate cancer

Identifiers

PMID29692694
PMCPMC5903470
OpenAlexW2792072792

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.